Practical Management of Thyroid Cancer: A Multidisciplinary Approach - Hardcover

9783031386046: Practical Management of Thyroid Cancer: A Multidisciplinary Approach
View all copies of this ISBN edition:
 
 

Top Search Results from the AbeBooks Marketplace

Stock Image

MALLICK U K
Published by Springer (2024)
ISBN 10: 3031386043 ISBN 13: 9783031386046
New Hardcover Quantity: 3
Seller:
Basi6 International
(Irving, TX, U.S.A.)

Book Description Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Seller Inventory # ABEOCT23-370228

More information about this seller | Contact seller

Buy New
US$ 146.26
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds
Seller Image

ISBN 10: 3031386043 ISBN 13: 9783031386046
New Hardcover Quantity: > 20
Print on Demand
Seller:
moluna
(Greven, Germany)

Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Covid-19 pandemic and thyroid cancer -- lessons learntArtificial intelligence in thyroid cancerGenomics based platform trials, tumour agnostic drugsDr Ujjal Mallick, MBBS&nbspMS&nbspFRCPE (Hon)&nbspFRCP (Hon) FRCR&nbspCons. Seller Inventory # 892114280

More information about this seller | Contact seller

Buy New
US$ 167.75
Convert currency

Add to Basket

Shipping: US$ 53.24
From Germany to U.S.A.
Destination, rates & speeds
Seller Image

Clive Harmer
ISBN 10: 3031386043 ISBN 13: 9783031386046
New Hardcover Quantity: 2
Print on Demand
Seller:
BuchWeltWeit Ludwig Meier e.K.
(Bergisch Gladbach, Germany)

Book Description Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Written by leading world experts, this third edition embraces the philosophy of international collaboration and disseminates the latest advances and transformative changes in the field of thyroid cancer.It provides a global health perspective, striving towards a uniform, equitable, evidence-based, cost-effective, practical, and patient-centred approach with high quality care crossing geographical boundaries. This book covers controversial issues and the most up-to-date management of differentiated, medullary, anaplastic, and rarer types of thyroid cancers together with survivorship issues and the lessons learnt during the Covid-19 Pandemic.The molecular landscape of thyroid cancers has a high frequency of oncogenic driver mutations and a high frequency of gene fusions treatable by new gene-specific systemic therapies. These include dual MAPK (Dabrafenib) / MEK (Trametinib) inhibition in BRAF V 600E mutated Anaplastic Thyroid Cancer, Larotrectinib, Entrectinib for NTRKgene fusion, Selpercartinib, Pralsetinib for RET fusion and mutations. These, newer and Master protocol trials, Tumour Agnostic drug development, Immune Checkpoint blockade and CAR-T therapy etc are discussed.The latest NICE and African Guidelines for Management are included. This would be of interest to readers as well.This book is aimed at thyroidologists of all disciplines, (in training or experts) students, non-specialist clinicians, nursing staff, all the disciplines involved in a multidisciplinary team such as surgeons - Head & Neck or Endocrine and General Surgeons, Oncologists, Endocrinologists, Nuclear Medicine Physicians, Nuclear Medicine Physicists, Radiologists, Pathologists, Specialist Nurses, Geneticists, Clinical Psychologists, Palliative Care Physicians and, in addition to AI in medicine, telemedicine experts, health policy makers, and scientists. 416 pp. Englisch. Seller Inventory # 9783031386046

More information about this seller | Contact seller

Buy New
US$ 203.61
Convert currency

Add to Basket

Shipping: US$ 25.00
From Germany to U.S.A.
Destination, rates & speeds
Seller Image

Clive Harmer
ISBN 10: 3031386043 ISBN 13: 9783031386046
New Hardcover Quantity: 1
Seller:
AHA-BUCH GmbH
(Einbeck, Germany)

Book Description Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Written by leading world experts, this third edition embraces the philosophy of international collaboration and disseminates the latest advances and transformative changes in the field of thyroid cancer.It provides a global health perspective, striving towards a uniform, equitable, evidence-based, cost-effective, practical, and patient-centred approach with high quality care crossing geographical boundaries. This book covers controversial issues and the most up-to-date management of differentiated, medullary, anaplastic, and rarer types of thyroid cancers together with survivorship issues and the lessons learnt during the Covid-19 Pandemic.The molecular landscape of thyroid cancers has a high frequency of oncogenic driver mutations and a high frequency of gene fusions treatable by new gene-specific systemic therapies. These include dual MAPK (Dabrafenib) / MEK (Trametinib) inhibition in BRAF V 600E mutated Anaplastic Thyroid Cancer, Larotrectinib, Entrectinib for NTRKgene fusion, Selpercartinib, Pralsetinib for RET fusion and mutations. These, newer and Master protocol trials, Tumour Agnostic drug development, Immune Checkpoint blockade and CAR-T therapy etc are discussed.The latest NICE and African Guidelines for Management are included. This would be of interest to readers as well.This book is aimed at thyroidologists of all disciplines, (in training or experts) students, non-specialist clinicians, nursing staff, all the disciplines involved in a multidisciplinary team such as surgeons - Head & Neck or Endocrine and General Surgeons, Oncologists, Endocrinologists, Nuclear Medicine Physicians, Nuclear Medicine Physicists, Radiologists, Pathologists, Specialist Nurses, Geneticists, Clinical Psychologists, Palliative Care Physicians and, in addition to AI in medicine, telemedicine experts, health policy makers, and scientists. Seller Inventory # 9783031386046

More information about this seller | Contact seller

Buy New
US$ 208.22
Convert currency

Add to Basket

Shipping: US$ 35.85
From Germany to U.S.A.
Destination, rates & speeds
Stock Image

Ujjal K. Mallick
ISBN 10: 3031386043 ISBN 13: 9783031386046
New Hardcover Quantity: 1
Seller:
Grand Eagle Retail
(Wilmington, DE, U.S.A.)

Book Description Hardcover. Condition: new. Hardcover. Written by leading world experts, this third edition embraces the philosophy of international collaboration and disseminates the latest advances and transformative changes in the field of thyroid cancer.It provides a global health perspective, striving towards a uniform, equitable, evidence-based, cost-effective, practical, and patient-centred approach with high quality care crossing geographical boundaries. This book covers controversial issues and the most up-to-date management of differentiated, medullary, anaplastic, and rarer types of thyroid cancers together with survivorship issues and the lessons learnt during the Covid-19 Pandemic.The molecular landscape of thyroid cancers has a high frequency of oncogenic driver mutations and a high frequency of gene fusions treatable by new gene-specific systemic therapies. These include dual MAPK (Dabrafenib) / MEK (Trametinib) inhibition in BRAF V 600E mutated Anaplastic Thyroid Cancer, Larotrectinib, Entrectinib for NTRKgene fusion, Selpercartinib, Pralsetinib for RET fusion and mutations. These, newer and Master protocol trials, Tumour Agnostic drug development, Immune Checkpoint blockade and CAR-T therapy etc are discussed.The latest NICE and African Guidelines for Management are included. This would be of interest to readers as well.This book is aimed at thyroidologists of all disciplines, (in training or experts) students, non-specialist clinicians, nursing staff, all the disciplines involved in a multidisciplinary team such as surgeons - Head & Neck or Endocrine and General Surgeons, Oncologists, Endocrinologists, Nuclear Medicine Physicians, Nuclear Medicine Physicists, Radiologists, Pathologists, Specialist Nurses, Geneticists, Clinical Psychologists, Palliative Care Physicians and, in addition to AI in medicine, telemedicine experts, health policy makers, and scientists. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Seller Inventory # 9783031386046

More information about this seller | Contact seller

Buy New
US$ 253.52
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds
Stock Image

Published by Springer (2024)
ISBN 10: 3031386043 ISBN 13: 9783031386046
New Hardcover Quantity: 4
Seller:
California Books
(Miami, FL, U.S.A.)

Book Description Condition: New. Seller Inventory # I-9783031386046

More information about this seller | Contact seller

Buy New
US$ 258.00
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds
Stock Image

Mallick, Ujjal K. (Editor)/ Harmer, Clive (Editor)
Published by Springer Nature (2024)
ISBN 10: 3031386043 ISBN 13: 9783031386046
New Hardcover Quantity: 2
Seller:
Revaluation Books
(Exeter, United Kingdom)

Book Description Hardcover. Condition: Brand New. 3rd edition. 415 pages. 10.00x7.01x1.06 inches. In Stock. Seller Inventory # x-3031386043

More information about this seller | Contact seller

Buy New
US$ 270.09
Convert currency

Add to Basket

Shipping: US$ 12.67
From United Kingdom to U.S.A.
Destination, rates & speeds
Stock Image

Published by Springer (2024)
ISBN 10: 3031386043 ISBN 13: 9783031386046
New Hardcover Quantity: 1
Seller:
Mispah books
(Redhill, SURRE, United Kingdom)

Book Description hardcover. Condition: New. New. book. Seller Inventory # ERICA82330313860436

More information about this seller | Contact seller

Buy New
US$ 258.42
Convert currency

Add to Basket

Shipping: US$ 31.68
From United Kingdom to U.S.A.
Destination, rates & speeds